Single dose of Sputnik V vaccine triggers strong antibody response: Study

 

A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study.

Previous studies have found that two doses of Sputnik V, a vector vaccine produced using a combination of two adenoviruses, results in 92 per cent efficacy against COVID-19 infection.


Adenoviruses are common viruses that cause a range of illness with cold-like symptoms such as fever and sore throat.

The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly. Click Here

Comments

Popular posts from this blog

Understanding the impact of cookieless targeting in digital advertising

Garmin Fenix7 series, epix smartwatches launched in India: Details here

Facebook parent Meta's social VR platform Horizon hits 300,000 users